Enhancing and sustaining access to medical oxygen innovations
Post-discharge malaria chemoprevention
Regional manufacturing for equitable access: Support to African manufacturers of postpartum hemorrhage (PPH), malaria and HIV products
Establish viable business models for access to monoclonal antibodies in low- and middle-income countries
Accelerate demand and adoption of tools and integrated delivery strategies for elimination of vertical transmission of HIV, syphilis, hepatitis B and Chagas in endemic areas
Accelerate and promote responsible introduction of new DR-TB drugs and regimens
Catalyzing adoption of an expanded vector control toolbox to fight malaria
Mitigating antimalarial drug resistance in Africa
